127 related articles for article (PubMed ID: 3774591)
21. Motor disturbances and neurotoxicity induced by centrally administered somatostatin and vasopressin in conscious rats: interactive effects of two neuropeptides.
Balaban CD; Fredericks DA; Wurpel JN; Severs WB
Brain Res; 1988 Mar; 445(1):117-29. PubMed ID: 2896527
[TBL] [Abstract][Full Text] [Related]
22. Role of arginine vasopressin in control of ACTH and LH release during stress.
Ono N; Bedran de Castro J; Khorram O; McCann SM
Life Sci; 1985 May; 36(18):1779-86. PubMed ID: 2984509
[TBL] [Abstract][Full Text] [Related]
23. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
24. The preovulatory prolactin surge is prolonged by a progesterone-dependent dopaminergic mechanism.
Arbogast LA; Ben-Jonathan N
Endocrinology; 1990 Jan; 126(1):246-52. PubMed ID: 1967162
[TBL] [Abstract][Full Text] [Related]
25. Small dose of domperidone potentiated the effects of TRH and serotonin on prolactin release in ovariectomized, estrogen-treated rats.
Pan JT; Teo KL
Neuroendocrinology; 1989 Oct; 50(4):387-91. PubMed ID: 2510048
[TBL] [Abstract][Full Text] [Related]
26. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
27. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
[TBL] [Abstract][Full Text] [Related]
28. Further evidence that peptide histidine isoleucine (PHI) may function as a prolactin releasing factor in rats.
Ohta H; Kato Y; Tojo K; Shimatsu A; Inoue T; Kabayama Y; Imura H
Peptides; 1985; 6(4):709-12. PubMed ID: 3934651
[TBL] [Abstract][Full Text] [Related]
29. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
30. Effect of dopamine injection into the anteroventral third ventricular region and the paraventricular nucleus on vasopressin secretion in conscious rats.
Yamaguchi K; Hama H; Watanabe K; Adachi C
Acta Endocrinol (Copenh); 1992 Nov; 127(5):420-4. PubMed ID: 1471453
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin analgesia: specificity of action and non-opioid effects.
Kordower JH; Bodnar RJ
Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
[TBL] [Abstract][Full Text] [Related]
32. Septal arginine vasopressin (AVP) receptor regulation in rats depleted of septal AVP following long-term castration.
Poulin P; Pittman QJ
J Neurosci; 1991 Jun; 11(6):1531-9. PubMed ID: 2045876
[TBL] [Abstract][Full Text] [Related]
33. Involvement of oxytocin in histamine- and stress-induced ACTH and prolactin secretion.
Kjaer A; Knigge U; Warberg J
Neuroendocrinology; 1995 Jun; 61(6):704-13. PubMed ID: 7659194
[TBL] [Abstract][Full Text] [Related]
34. Concomitant inhibition of pulsatile luteinizing hormone (LH) and stimulation of prolactin release by prostacyclin (PGI2) in ovariectomized (OVX) conscious rats.
Ottlecz A; McCann SM
Life Sci; 1988; 43(25):2077-85. PubMed ID: 3062293
[TBL] [Abstract][Full Text] [Related]
35. Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling.
Ciosek J; Guzek JW
J Physiol Pharmacol; 1998 Mar; 49(1):135-50. PubMed ID: 9594417
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of endogenous opioid peptides in prolactin secretion induced by alpha 2-adrenergic stimulation in rats.
Koshiyama H; Kato Y; Shimatsu A; Murakami Y; Hattori N; Ishikawa Y; Imura H
Proc Soc Exp Biol Med; 1989 Nov; 192(2):105-8. PubMed ID: 2813439
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of inhibitory action of kainic acid on prolactin secretion in male rats.
Pinilla L; Gonzalez D; Tena-Sempere M; Aguilar R; Aguilar E
J Endocrinol; 1996 Oct; 151(1):159-67. PubMed ID: 8943780
[TBL] [Abstract][Full Text] [Related]
38. Different effects of metoclopramide and domperidone on arginine-vasopressin secretion in man.
Chiodera P; Volpi R; Delsignore R; Marchesi C; Salati G; Camellini L; Rossi G; Coiro V
Br J Clin Pharmacol; 1986 Oct; 22(4):479-82. PubMed ID: 3768259
[TBL] [Abstract][Full Text] [Related]
39. Further evidence that central neurotensin inhibits pituitary prolactin secretion by stimulating dopamine release from the hypothalamus.
Tojo K; Kato Y; Kabayama Y; Ohta H; Inoue T; Imura H
Proc Soc Exp Biol Med; 1986 Apr; 181(4):517-22. PubMed ID: 3485291
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of prolactin secretion by gastrin releasing peptide (GRP) in the rat.
Matsushita N; Kato Y; Katakami H; Shimatsu A; Yanaihara N; Imura H
Proc Soc Exp Biol Med; 1983 Jan; 172(1):118-21. PubMed ID: 6828449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
